nicotinamide mononucleotide has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, J; Dunstan, CR; Jiang, L; Jiang, X; Lesani, P; Li, N; Li, Y; Lu, Z; Luo, D; Wang, G; Ye, Y; Zhang, W; Zreiqat, H | 1 |
| Huang, RX; Tao, J | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Osteoporosis
| Article | Year |
|---|---|
Nicotinamide Mononucleotide Alleviates Osteoblast Senescence Induction and Promotes Bone Healing in Osteoporotic Mice.
Topics: Animals; Humans; Mice; NAD; Nicotinamide Mononucleotide; Osteoblasts; Osteogenesis; Osteoporosis; Tumor Necrosis Factor-alpha | 2023 |
Nicotinamide mononucleotide attenuates glucocorticoid‑induced osteogenic inhibition by regulating the SIRT1/PGC‑1α signaling pathway.
Topics: Animals; Cell Line; Dexamethasone; Glucocorticoids; Humans; Mesenchymal Stem Cells; Mice, Inbred C57BL; Nicotinamide Mononucleotide; Osteogenesis; Osteoporosis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protective Agents; Signal Transduction; Sirtuin 1 | 2020 |